Ghana vs Yemen: Previously treated cases tested for RR-/MDR-TB
Ghana
100.0%
in 2024
Yemen
100.0%
in 2024
Ghana rank
1st
Yemen rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Ghana
- Yemen
How they compare
Ghana currently reports 100.0% against 100.0% in Yemen, a difference of 0.0%.
The two have swapped places 2 times across 14 shared years of data; in 2008 it was Yemen ahead.
Ghana ranks 1st and Yemen ranks 1st of 180 countries.
Across the 3 decades both report, Ghana averaged higher in 2 and Yemen in 1.
Head to head by decade
| Decade | Ghana | Yemen | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.0% | 14.0% | 1.0% | Yemen |
| 2010s | 71.9% | 21.5% | 50.4% | Ghana |
| 2020s | 98.6% | 60.0% | 38.6% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ghana or Yemen?
- Ghana, at 100.0% against 100.0% in Yemen as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ghana and Yemen?
- 0.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Yemen?
- 14 years are reported by both, from 2008 to 2024.
- How do Ghana and Yemen rank globally for previously treated cases tested for rr-/mdr-tb?
- Ghana ranks 1st and Yemen ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.